We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Glass Scaffolds Designed to Repair Bones Also Show Potential as Weight-Bearing Implants

By LabMedica International staff writers
Posted on 08 Aug 2013
Researchers have developed a type of glass implant that could soon be used to heal damaged bones in the legs, arms, and other areas of the body that are most exposed to the weight-bearing stresses.

This is the first time researchers have shown a glass implant strong enough to bear weight can also integrate with bone and promote bone growth, according to lead researcher Dr. More...
Mohamed N. Rahaman, professor of materials science and engineering at Missouri University of Science and Technology (S&T; Rolla, USA).

In earlier studies, the Missouri S&T researchers developed a glass implant strong enough to handle the weight and pressure of repetitive movement, such as walking or lifting. In their most recent study, published in the July 2013 issue, and available online in the journal Acta Biomaterialia, the researchers reported that in the form of a porous scaffolding, the glass implant, in addition, combines with bone and stimulates bone growth.

This fusion of strength and bone growth opens new possibilities for bone repair, according to Dr. Rahaman, who also directs Missouri S&T’s Center for Biomedical Science and Engineering, where the research was conducted. “Right now, there is no synthetic material that is practical for structural bone repair,” Dr. Rahaman said.

Traditional approaches to structural bone repair involve either the use of a porous metal, which does not reliably heal bone, or a bone allograft from a cadaver. Both approaches are costly and carry risks, according to Dr. Rahaman. He believes the type of glass implant developed in his center could provide a more feasible approach for repairing injured bones. The glass is bioactive, which means that it reacts when implanted in living tissue and convert to a bone-like material.

Dr. Rahaman and his coworkers, in their latest research, implanted bioactive glass scaffolds into sections of the calvarial bones (skullcaps) of laboratory rats, then examined how well the glass integrated with the surrounding bone and how quickly new bone grew into the scaffold. The scaffolds were created in Dr. Rahaman’s laboratory through a process known as robocasting, a computer-controlled technique to make materials from ceramic slurries, layer by layer, to ensure uniform structure for the porous material.

The Missouri S&T researchers, in previous studies with porous scaffolds of the silicate glass, known as 13-93, were found to have the same strength characteristics as cortical bone. Cortical bones are those outer bones of the body that bear the most weight and undergo the most repetitive stress. They include the long bones of the arms and legs.

However, what Dr. Rahaman and his colleagues could not determine was how well the silicate 13-93 bioactive glass scaffolds would integrate with bone or how quickly bone would grow into the scaffolding. “You can have the strongest material in the world, but it also must encourage bone growth in a reasonable amount of time,” stated Dr. Rahaman. He considers three to six months to be a reasonable time frame for completely regenerating an injured bone into one strong enough to bear weight.

In their study, the S&T researchers found that the bioactive glass scaffolds bonded quickly to bone and promoted a substantial amount of new bone growth within six weeks. Whereas the skullcap is not a load-bearing bone, it is principally a cortical bone. The aim of this research was to demonstrate how well this type of glass scaffolding, already shown to be strong, would interact with cortical bone.

Dr. Rahaman and his fellow researchers in the Center for Biomedical Science and Engineering are now studying true load-bearing bones. They are now evaluating the silicate 13-93 implants in the femurs (leg bones) of laboratory rats. In the future, Dr. Rahaman plans to experiment with modified glass scaffolds to see how well they enhance specific characteristics within bone. For instance, doping the glass with copper should promote the growth of blood vessels or capillaries within the new bone, while doping the glass with silver will give it antibacterial properties.


Related Links:

Missouri University of Science and Technology





Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.